Moreover, these PD MOs exhibit enhanced levels of PTX3 (pentraxin-related protein), which is consistent with reports citing a positive correlation between increased PTX3 levels and degree of PD severity in PD [192]. The gene discussed is PTX3; the disease is Parkinson disease.